# FDA 483 - DOH Central Pharmacy - July 28, 2025

Source: https://www.globalkeysolutions.net/records/483/doh-central-pharmacy/2e63bbe8-378e-4bfb-9291-b4cd93a9a372

> FDA 483 for DOH Central Pharmacy on July 28, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: DOH Central Pharmacy
- Inspection Date: 2025-07-28
- Product Type: drugs
- Office Name: Florida District Office
- Summary: An FDA inspection of DOH Central Pharmacy, a unit dose repacker in Tallahassee, FL, revealed significant deficiencies across multiple quality systems. Observations included inadequate quality control unit procedures, lack of equipment cleaning validations and proper record-keeping, unsupported expiration dates for repackaged drugs, and insufficient sampling of components and complaint handling. These issues indicate a need for comprehensive improvements in the firm's manufacturing and quality assurance practices.

## Related Officers

- [Dorothy P. Kramer](https://www.globalkeysolutions.net/people/dorothy-p-kramer/12e3c8b6-6359-43cc-96fd-ba2097225e3d)

Company: https://www.globalkeysolutions.net/companies/doh-central-pharmacy/85e1d2b3-dd22-4cb0-91fe-dbf0dae1c156

Office: https://www.globalkeysolutions.net/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9